Skip to main content


Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 14 Artikel )

24.11.2018 | Review Article | Ausgabe 2/2019

Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy

Samantha K. Korver, Rachel J. Gibson, Joanne M. Bowen, Janet K. Coller

13.11.2018 | Original Article | Ausgabe 2/2019

6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability

Shengnan Du, Jeffrey G. Sarver, Christopher J. Trabbic, Paul W. Erhardt, Allen Schroering, William A. Maltese

14.11.2018 | Original Article | Ausgabe 2/2019

Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines

Ajimu Keremu, Abudusaimi Aimaiti, Zhilin Liang, Xiaoguang Zou

14.11.2018 | Original Article | Ausgabe 2/2019

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals

Gordon T. Bolger, Albert Licollari, Amin Tan, Richard Greil, Brigitta Vcelar, Sigrun Greil-Ressler, Lukas Weiss, Charlotte Schönlieb, Teresa Magnes, Bianca Radl, Muhammed Majeed, Peter P. Sordillo

15.11.2018 | Original Article | Ausgabe 2/2019

Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B

Shuqi Chi, Yan Liu, Xing Zhou, Dilu Feng, Xianjin Xiao, Wenliang Li, Yingchao Zhao, Hongbo Wang

16.11.2018 | Original Article | Ausgabe 2/2019 Open Access

A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors

Masanori Toyoda, Koichiro Watanabe, Taro Amagasaki, Kazuto Natsume, Hiromi Takeuchi, Cornelia Quadt, Kuniaki Shirao, Hironobu Minami

20.11.2018 | Original Article | Ausgabe 2/2019

Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

Marina E. Cazzaniga, E. Ciruelos, A. Fabi, J. Garcia-Saenz, H. Lindman, D. Mavroudis, C. Schem, G. Steger, E. Timotheadou, K. Zaman, V. Torri, on behalf of the MACBETH Group

20.11.2018 | Original Article | Ausgabe 2/2019

Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias

Renu Singh, Shailly Mehrotra, Mathangi Gopalakrishnan, Ivana Gojo, Judith E. Karp, Jacqueline M. Greer, Alice Chen, Richard Piekarz, Brian F. Kiesel, Jogarao Gobburu, Michelle A. Rudek, Jan H. Beumer, on behalf of the ETCTN-6745 study team

22.11.2018 | Original Article | Ausgabe 2/2019 Open Access

Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin®), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors

Angelica L. Quartino, Hanbin Li, Whitney P. Kirschbrown, Ranvir Mangat, D. Russell Wada, Amit Garg, Jin Y. Jin, Bert Lum

24.11.2018 | Original Article | Ausgabe 2/2019

Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia

Sanjeev Khera, Amita Trehan, Prateek Bhatia, Minu Singh, Deepak Bansal, Neelam Varma

28.11.2018 | Original Article | Ausgabe 2/2019

A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities

Jennifer H. Foster, Patrick A. Thompson, M. Brooke Bernhardt, Judith F. Margolin, Susan G. Hilsenbeck, Eunji Jo, Deborah A. Marquez-Do, Michael E. Scheurer, Eric S. Schafer

30.11.2018 | Original Article | Ausgabe 2/2019

Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?

Huangliang Zheng, Jiaqi Li, Xiang Luo, Cong LI, Ling Hu, Qiujun Qiu, Junqiang Ding, Yanzhi Song, Yihui Deng

08.12.2018 | Original Article | Ausgabe 2/2019

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

Marianne Pavel, Françoise Borson-Chazot, Anne Cailleux, Dieter Hörsch, Harald Lahner, Rosario Pivonello, Libuse Tauchmanova, Christelle Darstein, Håkan Olsson, Fredrik Tiberg, Diego Ferone

12.12.2018 | Short Communication | Ausgabe 2/2019

Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

Abeer F. Alharbi, Robert A. Kratzke, Jonathan D’Cunha, Michael Anthony Maddaus, Kinjal Sanghavi, Mark N. Kirstein

Aktuelle Ausgaben


Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.